Synthesis and structure-activity relationships of novel warfarin derivatives.

作者: Markus Gebauer

DOI: 10.1016/J.BMC.2007.01.014

关键词:

摘要: 4-Hydroxycoumarins such as warfarin 1 have been the mainstay of oral anticoagulation therapy for over 20 years. Yet little detail is known about molecular interactions between 4-hydroxycoumarins with vitamin K epoxide reductase (VKER), inhibition which produces a deficiency and consequently K-dependent proteins involved in thrombus formation. Using probes, 4-sulfhydrylwarfarin 7 4-chlorowarfarin 10 it shown vitro that VKER by dependent on deprotonation 4-hydroxycoumarin moiety. In addition, nature substituent carbon 3 modulated inhibition. More specifically, linear isoprenyl side chain increased when compared to cyclical substituents present warfarin. An example an natural product ferulenol 19 derived from Ferula communis. Ferulenol confers approximately 22 times more potent than 1.5 rodenticide brodifacoum this assay. Based these data hypothesized bind active site thereby mimicking transition state elimination water substrate 2-hydroxyvitamin K.

参考文章(31)
Ralph S. Overman, Mark Arnold Stahmann, Charles Ferdinand Huebner, William R. Sullivan, Leonard Spero, David G. Doherty, Miyoshi Ikawa, Lloyd Graf, Saul Roseman, Karl Paul Link, STUDIES ON THE HEMORRHAGIC SWEET CLOVER DISEASE XIII. ANTICOAGULANT ACTIVITY AND STRUCTURE IN THE 4-HYDROXYCOUMARIN GROUP Journal of Biological Chemistry. ,vol. 153, pp. 5- 24 ,(1944) , 10.1016/S0021-9258(18)51207-2
TH Zytkovicz, GL Nelsestuen, [3H]diborane reduction of vitamin K-dependent calcium-binding proteins. Identification of a unique amino acid. Journal of Biological Chemistry. ,vol. 250, pp. 2968- 2972 ,(1975) , 10.1016/S0021-9258(19)41581-0
Harold A. Campbell, Karl Paul Link, STUDIES ON THE HEMORRHAGIC SWEET CLOVER DISEASE IV. THE ISOLATION AND CRYSTALLIZATION OF THE HEMORRHAGIC AGENT Journal of Biological Chemistry. ,vol. 138, pp. 21- 33 ,(1941) , 10.1016/S0021-9258(18)51407-1
Gary L. Nelsestuen, Amit M. Shah, Stephen B. Harvey, Vitamin K-dependent proteins Vitamins and Hormones Series. ,vol. 58, pp. 355- 389 ,(2000) , 10.1016/S0083-6729(00)58031-5
M J Fasco, P C Preusch, E Hildebrandt, J W Suttie, Formation of hydroxyvitamin K by vitamin K epoxide reductase of warfarin-resistant rats. Journal of Biological Chemistry. ,vol. 258, pp. 4372- 4380 ,(1983) , 10.1016/S0021-9258(18)32633-4
Susan Budavari, The Merck index Royal Society of Chemistry. ,(1998)
D. D. Perrin, Boyd Dempsey, Buffers for pH and metal ion control ,(1974)
E Chan, AJ McLachlan, M Pegg, AD MacKay, RB Cole, M Rowland, Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin [see comments] British Journal of Clinical Pharmacology. ,vol. 37, pp. 563- 569 ,(1994) , 10.1111/J.1365-2125.1994.TB04305.X
Lewis Rj, Lewis Rj, Lewis Rj, Trager Wf, Trager Wf, Trager Wf, Chan Kk, Chan Kk, Chan Kk, Robinson Aj, Robinson Aj, Robinson Aj, Warfarin metabolites: The anticoagulant activity and pharmacology of warfarin alcohols Journal of Laboratory and Clinical Medicine. ,vol. 81, pp. 925- 931 ,(1973) , 10.5555/URI:PII:0022214373903144